Jad Chahoud
Jad Chahoud/moffitt.org

Jad Chahoud: Big Step Forward in TNBC

Jad Chahoud, Medical Director of IPOP and Associate Member of the Department of Genitourinary Oncology at Moffitt Cancer Center, shared a post on LinkedIn:

“Big step forward in TNBC.

Early results from TROPION-Breast02 show Datroway (datopotamab deruxtecan) improved overall survival and progression-free survival vs chemotherapy in 1L metastatic triple-negative breast cancer patients ineligible for immunotherapy.

If confirmed, this could redefine care for many mTNBC patients!

Excited to see the full data at ESMO25!”

Read further.

More posts featuring Jad Chahoud.